Which has the lower trailing P/E, ABT or AMGN?

AMGN has the lower trailing P/E: ABT trades at 32.78 and AMGN at 23.45. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or AMGN?

Over the past five years, AMGN grew revenue faster — ABT at a 2.98% CAGR versus AMGN at 8.39%.

Does ABT or AMGN pay a bigger dividend?

ABT yields 2.40% and AMGN yields 2.56% based on trailing dividends and the latest price.

Is ABT or AMGN more profitable?

AMGN runs the higher net margin — ABT at 11.65% versus AMGN at 22.93%.

How have ABT and AMGN total returns compared?

Over the past 10 years, ABT delivered 11.77% and AMGN delivered 11.95% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Amgen Inc. (AMGN)

A side-by-side comparison of Abbott Laboratories and Amgen Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$176.43B

$101.96HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT

AMGN

Amgen Inc.

$203.66B

$377.35HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABT vs AMGN

growth of $100 · dividends reinvested · last 10y

ABT +199.3% (+11.6%/yr)AMGN +200.6% (+11.6%/yr)AMGN compounded faster over this window

ABT AMGN

ABT vs AMGN: by the numbers

•AMGN is the larger company ($203.66B vs $176.43B market cap).
•AMGN trades at the lower trailing earnings multiple (23.45 vs 32.78 P/E), one valuation lens rather than an overall verdict.
•AMGN converts more revenue to profit (22.93% vs 11.65% net margin).
•AMGN grew revenue faster over the past five years (8.39% vs 2.98% CAGR).
•AMGN pays the higher dividend yield (2.56% vs 2.40%).

Metrics side by side

Valuation

Metric	ABT	AMGN
P/E ratio	32.78	23.45
Forward P/E	18.48	16.35
P/S ratio	3.79	5.34
P/B ratio	3.45	17.42
EV / EBITDA	18.73	N/A
FCF yield	4.49%	5.00%

Profitability

Metric	ABT	AMGN
Gross margin	56.80%	72.65%
Operating margin	17.03%	33.18%
Net margin	11.65%	22.93%
ROE	10.61%	74.80%
ROIC	6.07%	14.22%

Dividends

Metric	ABT	AMGN
Dividend yield	2.40%	2.56%
Payout ratio	79.74%	60.91%

Growth (annualized)

Metric	ABT	AMGN
Revenue CAGR (5Y)	2.98%	8.39%
EPS CAGR (5Y)	8.22%	2.94%
FCF CAGR (5Y)	0.18%	-3.91%
Total return CAGR (5Y)	-2.42%	15.90%

Frequently asked

Which has the lower trailing P/E, ABT or AMGN?: AMGN has the lower trailing P/E: ABT trades at 32.78 and AMGN at 23.45. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or AMGN?: Over the past five years, AMGN grew revenue faster — ABT at a 2.98% CAGR versus AMGN at 8.39%.
Does ABT or AMGN pay a bigger dividend?: ABT yields 2.40% and AMGN yields 2.56% based on trailing dividends and the latest price.
Is ABT or AMGN more profitable?: AMGN runs the higher net margin — ABT at 11.65% versus AMGN at 22.93%.
How have ABT and AMGN total returns compared?: Over the past 10 years, ABT delivered 11.77% and AMGN delivered 11.95% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full AMGN analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Amgen P/E ratio Abbott Laboratories dividend yield Amgen dividend yield Abbott Laboratories ROE Amgen ROE Abbott Laboratories operating margin Amgen operating margin Abbott Laboratories revenue growth Amgen revenue growth Abbott Laboratories free cash flow Amgen free cash flow

Abbott Laboratories & Amgen appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest ROE Stocks Highest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.